Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.

worldpharmanewsSeptember 02, 2020

Tag: Sanofi , Kevzara , COVID-19

PharmaSources Customer Service